Trials / Conditions / Metastatic Angiosarcoma
Metastatic Angiosarcoma
3 registered clinical trials studyying Metastatic Angiosarcoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Stud NCT05026736 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma NCT04668300 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot B NCT03009201 | OHSU Knight Cancer Institute | Phase 1 |